https://www.selleckchem.com/products/mki-1.html
All of these data suggest that LI-M' is a promising PRRS vaccine candidate. © 2020 S. Karger AG, Basel.INTRODUCTION Peritoneal dialysis (PD) provides a safe, home-based continuous renal replacement therapy for patients. The adherence of the patients to the prescribed dialysis fluids cannot always be monitored by physicians. Remote monitoring automated peritoneal dialysis (RM-APD) can affect patients' compliance with treatment and, thus, clinical outcomes. OBJECTIVE We aimed to evaluate the clinical outcomes of patients with a remote acces
Curtir
Comentario
Compartilhar
